Sun Pharmaceutical Industries, Inc.

This study looked at the long-term safety and effectiveness of a drug called CTP-543 for adults with moderate to severe alopecia areata, a condition that causes patchy hair loss. About 400 people who had already completed a previous CTP-543 trial took the drug for up to 108 weeks…

This study tested whether a generic version of tretinoin gel works as well as the brand-name Retin-A Micro for treating acne. Over 1,000 people aged 12 to 40 with mild to moderate acne took part. The goal was to see if the generic gel is equally safe and effective at reducing pim…

This study tested a cream called tapinarof on 575 adults with mild-to-moderate plaque psoriasis. The goal was to see if it safely clears skin patches better than a placebo cream. Participants applied the cream daily for several weeks, and doctors measured improvement in their pso…